-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Receives Multiple Prestigious Awards in the Pharmaceutical Packaging Sector
Category:
发布时间：2024-04-17
【概要描述】
On April 16, on the eve of the China Pharmaceutical Packaging Association’s 2024 Annual Conference, a number of member organizations and individuals who have made significant contributions to advancing the industry and promoting high-quality development were recognized and honored. Shijiazhuang Sihua Pharmaceutical and Group Bosheng Medical Devices were among the recipients of multiple prestigious awards.
On April 16, on the eve of the China Pharmaceutical Packaging Association’s 2024 Annual Conference, a number of member organizations and individuals who have made significant contributions to advancing the industry and promoting high-quality development were recognized and honored. Shijiazhuang Sihua Pharmaceutical and Group Bosheng Medical Devices were among the recipients of multiple prestigious awards.
Shijiazhuang Sihua Pharmaceutical was honored with three prestigious awards: Outstanding Member in Pharmaceutical Packaging, Pioneer in Pharmaceutical Packaging Innovation, and Contributor to Standardization Efforts. Meanwhile, the Group’s Jiangsu Bosheng was recognized with four distinguished accolades: Outstanding Member in Pharmaceutical Packaging, Pioneer in Pharmaceutical Packaging Innovation, Excellent Supply Chain Partner in Pharmaceutical Packaging, and Contributor to Standardization Efforts.
In recent years, while deepening its core business, the Group has focused on key technological development trends in pharmaceutical packaging materials and the pharmaceutical industry. It has established a quality control system and standards for raw materials at the very source of medical packaging production, actively aligned its practices with international best practices, and promoted the development and enhancement of pharmaceutical packaging standards. The Group has also repeatedly chaired or participated in the formulation of national and industry standards.
The Group continues to invest heavily in the innovative development of pharmaceutical packaging materials, having established a comprehensive product value chain and portfolio that encompasses independent R&D and industrialization of new medical packaging materials, the application of pharmaceutical packaging materials, and pharmaceutical product development and manufacturing. Guided by market demand and driven by the new-product-development strategy of “expanding product variety, upgrading technological capabilities, and enhancing quality and efficiency,” the Group is accelerating its transformation, upgrading, and pursuit of high-quality, innovation-driven growth. It is focusing on fundamental, innovative, and forward-looking research into rubber stoppers, co-extruded films, and cutting-edge medical packaging materials; advancing new-product R&D and technological upgrades; speeding up the realization of high-level scientific and technological self-reliance and strength; and continuously empowering corporate innovation and green, high-quality development.
Moving forward, the Group will leverage expert think-tank resources from the China Pharmaceutical Packaging Association, universities, research institutes, and other institutions. By closely monitoring industry development trends, market demand, and cutting-edge innovation hotspots, and by integrating new technologies, emerging regulations, and evolving customer needs, the Group will conduct in-depth research and development on critical core technologies. This effort will accelerate improvements in product drug safety, environmental sustainability, and intelligent multifunctionality, while actively leading and participating in the formulation of more packaging material products and industry standards. In areas where the Group holds competitive advantages, it will assume a pioneering and exemplary role in the industry, continuously fostering and expanding new drivers of productivity to meet the new developments and requirements of the pharmaceutical industry’s upgrade. The Group will also expedite the establishment of a national-level enterprise technology center in the pharmaceutical packaging materials sector, thereby supporting its high-quality development.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091